Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention

Objective The effects of ticagrelor in the subpopulation of patients with ST-elevation myocardial infarction (STEMI) were consistent with those observed in the overall Platelet Inhibition and Patient Outcomes (PLATO) study. However, this subgroup included patients initially or ultimately treated con...

Full description

Saved in:
Bibliographic Details
Main Authors: Velders, Matthijs A. (Author) , Abtan, Jérémie (Author) , Angiolillo, Dominick J. (Author) , Ardissino, Diego (Author) , Harrington, Robert A. (Author) , Hellkamp, Anne (Author) , Himmelmann, Anders (Author) , Husted, Steen (Author) , Katus, Hugo (Author) , Meier, Bernhard (Author) , Schulte, Phillip J. (Author) , Storey, Robert F. (Author) , Wallentin, Lars (Author) , Steg, Philippe Gabriel (Author) , James, Stefan K. (Author)
Format: Article (Journal)
Language:English
Published: 4 February 2016
In: Heart
Year: 2016, Volume: 102, Issue: 8, Pages: 617-625
ISSN:1468-201X
DOI:10.1136/heartjnl-2015-308963
Online Access:Verlag, Volltext: https://doi.org/10.1136/heartjnl-2015-308963
Verlag, Volltext: https://heart.bmj.com/content/102/8/617
Get full text
Author Notes:Matthijs A. Velders, Jérémie Abtan, Dominick J. Angiolillo, Diego Ardissino, Robert A. Harrington, Anne Hellkamp, Anders Himmelmann, Steen Husted, Hugo A. Katus, Bernhard Meier, Phillip J. Schulte, Robert F. Storey, Lars Wallentin, Philippe Gabriel Steg, Stefan K. James, on behalf of thePLATO Investigators

MARC

LEADER 00000caa a2200000 c 4500
001 1685811795
003 DE-627
005 20220817191836.0
007 cr uuu---uuuuu
008 191217s2016 xx |||||o 00| ||eng c
024 7 |a 10.1136/heartjnl-2015-308963  |2 doi 
035 |a (DE-627)1685811795 
035 |a (DE-599)KXP1685811795 
035 |a (OCoLC)1341283137 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Velders, Matthijs A.  |e VerfasserIn  |0 (DE-588)1129390187  |0 (DE-627)883958694  |0 (DE-576)486385892  |4 aut 
245 1 0 |a Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention  |c Matthijs A. Velders, Jérémie Abtan, Dominick J. Angiolillo, Diego Ardissino, Robert A. Harrington, Anne Hellkamp, Anders Himmelmann, Steen Husted, Hugo A. Katus, Bernhard Meier, Phillip J. Schulte, Robert F. Storey, Lars Wallentin, Philippe Gabriel Steg, Stefan K. James, on behalf of thePLATO Investigators 
264 1 |c 4 February 2016 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.12.2019 
520 |a Objective The effects of ticagrelor in the subpopulation of patients with ST-elevation myocardial infarction (STEMI) were consistent with those observed in the overall Platelet Inhibition and Patient Outcomes (PLATO) study. However, this subgroup included patients initially or ultimately treated conservatively. The aim of this study is to compare treatment using ticagrelor with treatment using clopidogrel in patients with STEMI undergoing primary percutaneous coronary intervention (PCI). - Methods This post-hoc subgroup analysis compared ticagrelor with clopidogrel in 4949 PLATO patients with STEMI that were treated with primary PCI within 12 h of admission. The primary endpoint was cardiovascular death, myocardial infarction or stroke. The safety endpoint consisted of any major bleeding. Secondary endpoints included stent thrombosis. The analysis was not adequately powered to establish significance of any treatment effects. - Results During a median of 286 days, the primary endpoint occurred in 7.9% of ticagrelor-treated patients versus 8.6% of clopidogrel-treated patients (HR 0.91, 95% CI 0.75 to 1.12, p=0.38). Major bleeding occurred in 6.7% in ticagrelor-treated patients versus 6.8% of clopidogrel-treated patients (HR 0.97, 95% CI 0.77 to 1.22, p=0.79). No interactions were observed for the treatment effect of ticagrelor versus clopidogrel on the primary efficacy (p=0.40) and primary safety endpoints (p=0.15) as compared with the full PLATO population. Treatment with ticagrelor versus clopidogrel reduced the occurrence of definite stent thrombosis (HR 0.58, 95% CI 0.37 to 0.89, p=0.013). - Conclusions In the subset of patients with STEMI treated with primary PCI, ticagrelor compared with clopidogrel was safe, and efficacy outcomes were consistent with the overall PLATO trial. - Trial registration number NCT00391872; Results. 
700 1 |a Abtan, Jérémie  |e VerfasserIn  |4 aut 
700 1 |a Angiolillo, Dominick J.  |e VerfasserIn  |4 aut 
700 1 |a Ardissino, Diego  |e VerfasserIn  |4 aut 
700 1 |a Harrington, Robert A.  |e VerfasserIn  |4 aut 
700 1 |a Hellkamp, Anne  |e VerfasserIn  |4 aut 
700 1 |a Himmelmann, Anders  |e VerfasserIn  |4 aut 
700 1 |a Husted, Steen  |e VerfasserIn  |4 aut 
700 1 |a Katus, Hugo  |d 1951-  |e VerfasserIn  |0 (DE-588)108916618  |0 (DE-627)577155040  |0 (DE-576)289625076  |4 aut 
700 1 |a Meier, Bernhard  |e VerfasserIn  |4 aut 
700 1 |a Schulte, Phillip J.  |e VerfasserIn  |4 aut 
700 1 |a Storey, Robert F.  |e VerfasserIn  |4 aut 
700 1 |a Wallentin, Lars  |e VerfasserIn  |4 aut 
700 1 |a Steg, Philippe Gabriel  |e VerfasserIn  |4 aut 
700 1 |a James, Stefan K.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Heart  |d [London] : BMJ Publ. Group, 1996  |g 102(2016), 8, Seite 617-625  |h Online-Ressource  |w (DE-627)269538925  |w (DE-600)1475501-4  |w (DE-576)078940427  |x 1468-201X  |7 nnas  |a Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention 
773 1 8 |g volume:102  |g year:2016  |g number:8  |g pages:617-625  |g extent:9  |a Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention 
856 4 0 |u https://doi.org/10.1136/heartjnl-2015-308963  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://heart.bmj.com/content/102/8/617  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20191217 
993 |a Article 
994 |a 2016 
998 |g 108916618  |a Katus, Hugo  |m 108916618:Katus, Hugo  |d 910000  |d 910100  |e 910000PK108916618  |e 910100PK108916618  |k 0/910000/  |k 1/910000/910100/  |p 9 
999 |a KXP-PPN1685811795  |e 3566278955 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"9 S."}],"id":{"doi":["10.1136/heartjnl-2015-308963"],"eki":["1685811795"]},"title":[{"title":"Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention","title_sort":"Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"4 February 2016"}],"relHost":[{"recId":"269538925","origin":[{"dateIssuedKey":"1996","publisherPlace":"[London]","publisher":"BMJ Publ. Group","dateIssuedDisp":"1996-"}],"title":[{"title":"Heart","title_sort":"Heart"}],"id":{"zdb":["1475501-4"],"eki":["269538925"],"issn":["1468-201X"]},"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["75.1996 -"],"note":["Gesehen am 12.12.12"],"language":["eng"],"part":{"volume":"102","year":"2016","extent":"9","pages":"617-625","issue":"8","text":"102(2016), 8, Seite 617-625"},"titleAlt":[{"title":"Heart and Education in Heart"},{"title":"Education in heart"},{"title":"Heart online"}],"disp":"Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary interventionHeart","type":{"bibl":"periodical","media":"Online-Ressource"}}],"language":["eng"],"name":{"displayForm":["Matthijs A. Velders, Jérémie Abtan, Dominick J. Angiolillo, Diego Ardissino, Robert A. Harrington, Anne Hellkamp, Anders Himmelmann, Steen Husted, Hugo A. Katus, Bernhard Meier, Phillip J. Schulte, Robert F. Storey, Lars Wallentin, Philippe Gabriel Steg, Stefan K. James, on behalf of thePLATO Investigators"]},"note":["Gesehen am 17.12.2019"],"recId":"1685811795","person":[{"family":"Velders","role":"aut","given":"Matthijs A.","display":"Velders, Matthijs A."},{"given":"Jérémie","display":"Abtan, Jérémie","role":"aut","family":"Abtan"},{"given":"Dominick J.","display":"Angiolillo, Dominick J.","family":"Angiolillo","role":"aut"},{"role":"aut","family":"Ardissino","given":"Diego","display":"Ardissino, Diego"},{"family":"Harrington","role":"aut","display":"Harrington, Robert A.","given":"Robert A."},{"family":"Hellkamp","role":"aut","given":"Anne","display":"Hellkamp, Anne"},{"given":"Anders","display":"Himmelmann, Anders","role":"aut","family":"Himmelmann"},{"display":"Husted, Steen","given":"Steen","role":"aut","family":"Husted"},{"family":"Katus","role":"aut","display":"Katus, Hugo","given":"Hugo"},{"given":"Bernhard","display":"Meier, Bernhard","family":"Meier","role":"aut"},{"family":"Schulte","role":"aut","given":"Phillip J.","display":"Schulte, Phillip J."},{"family":"Storey","role":"aut","display":"Storey, Robert F.","given":"Robert F."},{"family":"Wallentin","role":"aut","display":"Wallentin, Lars","given":"Lars"},{"given":"Philippe Gabriel","display":"Steg, Philippe Gabriel","role":"aut","family":"Steg"},{"family":"James","role":"aut","display":"James, Stefan K.","given":"Stefan K."}]} 
SRT |a VELDERSMATSAFETYANDE4201